1 / 3
google
Article details
- Package size
- 100
- Selling units
- 100
- Measure
- g
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
cholecalciferolum
|
750.0 UI | Substance | Wirkstoff (Principe actif) |
|
calcium
|
140.0 MG | Substance | Wirkstoff (Principe actif) |
|
calcii hydrogenophosphas dihydricus
|
600.0 MG | Substance | WIZUS |
|
saccharum
|
196.14 MG | Substance | HBESI |
|
glucosum
|
189.0 MG | Substance | HBESI |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
sojae oleum partim hydrogenatum
|
0.62 MG | Substance | HBESI |
|
E 307
|
- | Substance | ANTON |
Authorization holder
Lagap SA
6943 Vezia
Authorization information
- Swissmedic authorization number
- 19035
- Drug name
- Decalcit, polvere orale
- Galenic form
- PULOR
- ATC Code
- A12AX
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 01/10/1953
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.02.51
- Domain
- Human medicine
Package details
- Description (FR)
- DECALCIT pdr 100 g
- Description (DE)
- DECALCIT Plv 100 g
- Market launch
- 01/10/1953
- Market withdrawal
- 30/06/2025
- Narcotic (BTM)
- No